Cellebrite DI Ltd. provides digital intelligence solutions for the public and private sectors globally. The company is headquartered in Petah Tikva, Israel.
| Revenue (TTM) | $514.29M |
| Gross Profit (TTM) | $426.66M |
| EBITDA | $78.43M |
| Operating Margin | 5.30% |
| Return on Equity | 12.40% |
| Return on Assets | 3.92% |
| Revenue/Share (TTM) | $2.09 |
| Book Value | $2.15 |
| Price-to-Book | 5.37 |
| Price-to-Sales (TTM) | 5.56 |
| EV/Revenue | 4.805 |
| EV/EBITDA | 23.96 |
| Quarterly Earnings Growth (YoY) | -67.90% |
| Quarterly Revenue Growth (YoY) | 15.80% |
| Shares Outstanding | $251.34M |
| Float | $99.27M |
| % Insiders | 43.55% |
| % Institutions | 53.22% |
Volatility is currently expanding
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
New York, New York--(Newsfile Corp. - October 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Boston, Massachusetts--(Newsfile Corp. - October 2, 2026) - Block & Leviton is investigating Cellebrite DI (NASDAQ: CLBT) for potential securities law violations. Investors who have lost money in their Cellebrite DI investment should contact the firm to learn more about how they might recover those losses.
New York, New York--(Newsfile Corp. - October 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
New York, New York--(Newsfile Corp. - September 30, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CLBT and any ticker you trade — then tracks every position and per-strategy win rate.
